Paula Aguilera

Phase 3 Trial of RNAi Therapeutic Givosiran for Acute Intermittent Porphyria

Manisha Balwani, Eliane Sardh, Paolo Ventura et al. · New England Journal of Medicine · 2020 · 562 citations · Full text

Genetic Abnormalities in Large to Giant Congenital Nevi: Beyond NRAS Mutations

Vanessa Martins da Silva, Estefanía Martinez-Barrios, Gemma Tell‐Martí et al. · Journal of Investigative Dermatology · 2018 · 99 citations

Developmental Anomaly, Mendelian Disorder, Genetic Disorder +8

Dermoscopic Clues for Diagnosing Melanomas That Resemble Seborrheic Keratosis

Cristina Carrera, Sònia Segura, Paula Aguilera et al. · JAMA Dermatology · 2017 · 74 citations · Full text

Efficacy and safety of givosiran for acute hepatic porphyria: 24‐month interim analysis of the randomized phase 3 ENVISION study

P. Ventura, Herbert L. Bonkovsky, Laurent Gouya et al. · Liver International · 2021 · 74 citations · Full text

Increased prevalence of lung, breast, and pancreatic cancers in addition to melanoma risk in families bearing the cyclin-dependent kinase inhibitor 2A mutation: Implications for genetic counseling

Míriam Potrony, Joan Anton Puig‐Butillé, Paula Aguilera et al. · Journal of the American Academy of Dermatology · 2014 · 65 citations · Full text

Cancer Risk, Cancer Epidemiology, Medicine +12